Chemotherapy treatment has been shown to reduce the adipocyte content in AML patients, possibly by promoting the overexpression and secretion of GDF15 from bone marrow mononuclear cells (Liu et al., 2018). The gene discussed is GDF15; the disease is acute myeloid leukemia.